June 24, 2009 - Naviscan Inc., a molecular breast imaging (MBI) provider, has entered into a distribution agreement with Hae Dong Co. Ltd. to market and serve Naviscan’s high-resolution organ-specific PET scanner, whose breast application is known as positron emission mammography (PEM), in the Republic of South Korea.
The first unit will be installed at Seoul National University Hospital, where it will be available to physicians and researchers while awaiting Korean FDA approval.
Naviscan manufactures is a commercially available PEM imaging scanner and PEM-guided biopsy system. The scanner uses PET technology to produce tomographic images that allow physicians to visualize breast tumors down to 2 mm, the width of a grain of rice. The scanner is the size of a mammography unit and uses gentle breast immobilization, allowing for greater patient comfort, as well as reducing motion artifact and improving image resolution.
Hae Dong Co. Ltd. is the leader in the Korean market for Radiation Oncology products and Nuclear Medicine. As a distributor of Philips whole-body PET scanners, and producer and distributor of Fluorodeoxyglucose or FDG (the positron-emitting radioactive isotope used in PET), the Naviscan PEM scanner complements Hae Dong’s molecular imaging suite of solutions.
Additional distributorships have been selected in Mexico, Venezuela and Colombia. Naviscan will be launching in those countries by the fourth quarter of 2009.
For more information: www.naviscan.com
October 19, 2026 
